Boston Scientific (BSX) vs Stryker (SYK)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Stryker (SYK) has outperformed Boston Scientific (BSX) over the past year, losing 26.2% versus a loss of 56.6%. Over five years, SYK leads with a +4.0% price change compared with -3.1% for BSX. Stryker is the larger company by market cap ($106.38 billion vs $61.93 billion), about 1.7 times the size, while Boston Scientific is growing revenue faster (+19.9% vs +11.2%).
On valuation, Boston Scientific trades at a lower forward P/E (12.6x vs 16.6x for Stryker). Stryker pays a dividend yielding 1.25%, while Boston Scientific does not currently pay one. Boston Scientific converts more of its revenue into profit, with a net margin of 14.4% versus 12.9%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BSX | SYK |
|---|---|---|
| Share price | $42.73 | $277.33 |
| Market cap | $61.93B | $106.38B |
| 1-day change | +1.64% | +0.13% |
| YTD return | -55.91% | -21.20% |
| 1-year return | -56.57% | -26.20% |
| 5-year return | -3.13% | +4.00% |
| P/E ratio (TTM) | 17.30 | 28.74 |
| Forward P/E | 12.63 | 16.61 |
| EPS (TTM) | $2.47 | $9.65 |
| Dividend yield | 0.00% | 1.25% |
| Annual dividend | $0.00 | $3.48 |
| Revenue (latest FY) | $20.07B | $25.12B |
| Revenue growth (YoY) | +19.87% | +11.16% |
| Net income (latest FY) | $2.89B | $3.25B |
| Gross margin | 69.01% | 63.96% |
| Operating margin | 18.00% | 19.47% |
| Net margin | 14.41% | 12.92% |
| 52-week high | $105.65 | $392.55 |
| 52-week low | $41.39 | $267.00 |
| Distance from 52-week high | -59.56% | -29.35% |
| Analyst consensus | buy | buy |
| Avg. price target upside | +40.18% | +32.03% |
| Average volume | 19.87M | 2.64M |
| Shares outstanding | 1.45B | 383.57M |
| Employees | 59,000 | 56,000 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- SYK has outperformed BSX by 30.4 percentage points over the past year.
- Stryker trades at a higher earnings multiple (28.7x vs 17.3x trailing P/E).
- Stryker offers a meaningfully higher dividend yield (1.25% vs 0.00%).
- Boston Scientific grew revenue faster in its latest fiscal year (+19.87% vs +11.16%).
About Boston Scientific
BSX stock →Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in two segments, MedSurg and Cardiovascular.
Health Care · Medical/Dental Instruments · 59,000 employees
About Stryker
SYK stock →Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics.
Health Care · Medical/Dental Instruments · 56,000 employees
BSX vs SYK FAQ
Which is bigger, Boston Scientific or Stryker?
Stryker (SYK) is larger, with a market capitalization of $106.38B compared with $61.93B for Boston Scientific (BSX).
Which stock has performed better over the past year, BSX or SYK?
SYK returned -26.20% over the past 12 months, compared with -56.57% for BSX (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, BSX or SYK?
BSX has the lower trailing P/E at 17.3, versus 28.7 for SYK. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Boston Scientific or Stryker?
Stryker pays a dividend yielding 1.25%, while Boston Scientific does not currently pay a regular dividend.
Are Boston Scientific and Stryker in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.